Medistim ASA (LON:0OCD)
London
· Delayed Price · Currency is GBP · Price in NOK 192.50
+9.50 (5.19%)
Mar 12, 2025, 8:09 AM BST
Medistim ASA Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 254 | 193 | 303 | 355 | 561 | 389 | Upgrade
|
| Market Cap Growth | -36.44% | -36.44% | -14.73% | -36.70% | 44.30% | 29.63% | Upgrade
|
| Enterprise Value | 244 | 184 | 293 | 346 | 556 | 382 | Upgrade
|
| Last Close Price | 13.24 | 10.55 | 16.15 | 18.68 | 29.15 | 17.87 | Upgrade
|
| PE Ratio | 34.85 | 26.37 | 37.68 | 36.99 | 73.63 | 65.58 | Upgrade
|
| PS Ratio | 4.87 | 4.87 | 7.51 | 8.67 | 16.02 | 12.77 | Upgrade
|
| PB Ratio | 6.27 | 6.27 | 9.83 | 11.47 | 21.87 | 17.72 | Upgrade
|
| P/TBV Ratio | 7.28 | 7.28 | 11.10 | 12.71 | 24.26 | 20.30 | Upgrade
|
| P/FCF Ratio | 19.34 | 19.34 | 40.42 | 40.45 | 55.79 | 68.24 | Upgrade
|
| P/OCF Ratio | 19.34 | 19.34 | 34.56 | 37.15 | 52.55 | 61.38 | Upgrade
|
| EV/Sales Ratio | 5.99 | 4.65 | 7.27 | 8.45 | 15.87 | 12.56 | Upgrade
|
| EV/EBITDA Ratio | 22.14 | 17.19 | 25.83 | 26.11 | 52.09 | 42.60 | Upgrade
|
| EV/EBIT Ratio | 25.72 | 19.97 | 28.83 | 29.10 | 59.73 | 46.87 | Upgrade
|
| EV/FCF Ratio | 18.49 | 18.49 | 39.15 | 39.43 | 55.26 | 67.11 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.04 | 0.05 | 0.08 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.16 | 0.16 | 0.11 | 0.10 | 0.18 | 0.35 | Upgrade
|
| Debt / FCF Ratio | 0.18 | 0.18 | 0.18 | 0.16 | 0.20 | 0.59 | Upgrade
|
| Asset Turnover | 1.04 | 1.04 | 1.05 | 1.10 | 1.12 | 1.04 | Upgrade
|
| Inventory Turnover | 0.74 | 0.74 | 0.86 | 1.01 | 0.92 | 0.76 | Upgrade
|
| Quick Ratio | 2.50 | 2.50 | 2.53 | 2.64 | 2.62 | 2.23 | Upgrade
|
| Current Ratio | 4.00 | 4.00 | 4.15 | 3.87 | 3.95 | 4.13 | Upgrade
|
| Return on Equity (ROE) | 24.88% | 24.88% | 27.12% | 33.83% | 32.30% | 28.11% | Upgrade
|
| Return on Assets (ROA) | 15.16% | 15.16% | 16.62% | 19.93% | 18.52% | 17.50% | Upgrade
|
| Return on Capital (ROIC) | 18.68% | 18.68% | 20.53% | 24.69% | 22.15% | 20.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.03% | 28.03% | 31.95% | 36.90% | 34.08% | 33.35% | Upgrade
|
| Earnings Yield | 2.87% | 3.79% | 2.65% | 2.70% | 1.36% | 1.52% | Upgrade
|
| FCF Yield | 5.17% | 5.17% | 2.47% | 2.47% | 1.79% | 1.47% | Upgrade
|
| Dividend Yield | 0.18% | 4.00% | 2.16% | 2.03% | 1.08% | 1.43% | Upgrade
|
| Payout Ratio | 0.00% | - | 79.15% | 60.01% | 60.11% | 72.13% | Upgrade
|
| Buyback Yield / Dilution | -0.10% | -0.10% | -0.10% | -0.15% | -0.07% | -0.13% | Upgrade
|
| Total Shareholder Return | 0.08% | 3.90% | 2.05% | 1.88% | 1.01% | 1.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.